Patient iP provides clinical trial matching technology that enables CROs, life sciences companies, and their networked study sites to access de-identified, aggregated patient data from existing electronic health record systems. Discrete study protocols are loaded and applied against the database, and matched patients and their sites are identified based on inclusion and exclusion criteria. The company has completed its platform development and has launched a number of clinical trial study sites. It recently received a letter of commitment from a large CRO. Patient iP intends to use the funds from the financing to accelerate sales and marketing and to expand its implementation team. The company was founded in 2014 by Michael J. Margiotta and is based in Victor, NY.

Total raised

$2M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2016